Interleukin-4 changes the transcriptome, ECM-associated components and function of mare endometrial fibroblast: Insights from healthy and fibrotic cells

In: Cell and Tissue Research · 2026 · vol. 403(2) · doi:10.1007/s00441-026-04049-6 · PMID:41729313 · W7131124559
article OA: hybrid CC0
AI-generated summary by claude@2026-06, 2026-06-14

Interleukin-4 reprograms mare endometrial fibroblasts, altering gene expression, extracellular matrix components, and cell function in a manner dependent on the fibrosis status of the tissue of origin.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-14 · read from full text

The study investigated how interleukin-4 (IL-4) reprograms primary mare endometrial fibroblasts derived from healthy versus fibrotic endometrium (endometrosis) using ex vivo IL-4 exposure for 48 or 96 hours followed by bulk transcriptomic analyses and assessments of extracellular matrix (ECM)–associated components and function. IL-4 altered the fibroblast transcriptome with thousands of differentially expressed genes linked to metabolism, ECM organization/remodeling, and fibrogenesis-related signaling, and it also changed long non-coding RNA expression with lncRNAs associated with inflammation and cytokine signaling pathways. Functionally, IL-4 increased proliferation and viability in fibroblasts from both healthy and fibrotic tissues, while reducing migration in non-fibrotic fibroblasts after longer exposure, and it changed matrix metalloproteinase mRNA, protein abundance, and gelatinolytic activity in a fibrosis-stage-dependent manner. The paper’s limitation is that these findings come from IL-4 stimulation of fibroblasts in a large-animal in vitro setup rather than direct in vivo mechanistic tracing. Relevance to endometriosis: the paper is centrally about endometrosis (equine endometrial fibrosis) and fibroblast remodeling induced by IL-4, providing a mechanistic analog for immune–stromal interactions relevant to endometriosis and adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Fibrosis remains incompletely understood, particularly in terms of how immune mediators shape stromal programs. We used a spontaneous large‑animal model—endometrosis (equine endometrial fibrosis) to define how interleukin‑4 (IL‑4) reprograms fibroblasts from healthy and fibrotic endometrium. Primary fibroblasts were exposed to IL‑4 (10 ng/mL) for 48 or 96 h. At 48 h, bulk transcriptomes revealed 1307 differentially expressed genes (DEGs; 648 up, 659 down) and 1271 DEGs (645 up, 626 down) in fibroblasts derived from endometria without or with endometrosis, respectively. Enrichment analyses implicated cellular metabolism, extracellular matrix (ECM) organization and remodeling, and signaling pathways commonly linked to fibrogenesis. IL‑4 also affected the long non‑coding RNA (lncRNA) expression, with 143 and 135 differentially expressed lncRNAs in fibroblasts derived from healthy or fibrotic endometria, respectively; linking these lncRNAs to DEGs involved in inflammation, ECM organization, and cytokine signaling. Moreover, IL‑4 increased proliferation and viability in fibroblasts derived from healthy or fibrotic endometria, while selectively reducing migration in fibroblasts derived from endometria without fibrosis after 96 h. IL‑4 further altered mRNA expression, protein abundance, and gelatinolytic activity of matrix metalloproteinases in a manner contingent on the fibrosis status of the tissue of origin, indicating stage‑dependent control of ECM turnover. Collectively, these data identify IL‑4 as a potent modulator of fibroblast function in a spontaneous large‑animal fibrosis model, revealing fibrosis stage‑dependent responses. Interleukin-4 (IL-4) modulates the transcriptome, extracellular matrix (ECM)–associated components, and functional characteristics of mare endometrial fibroblasts derived from healthy and fibrotic uteri. IL-4 treatment induces distinct transcriptomic and proteomic changes, alters cell proliferation, migration, collagen contractility, and MMP activity, and elicits differential responses between non-fibrotic and fibrotic cells, highlighting fibrosis-dependent effects of IL-4 on endometrial remodeling.
Full text 15,135 characters · extracted from oa-html · 3 sections · click to expand

Abstract

Fibrosis remains incompletely understood, particularly in terms of how immune mediators shape stromal programs. We used a spontaneous large‑animal model—endometrosis (equine endometrial fibrosis) to define how interleukin‑4 (IL‑4) reprograms fibroblasts from healthy and fibrotic endometrium. Primary fibroblasts were exposed to IL‑4 (10 ng/mL) for 48 or 96 h. At 48 h, bulk transcriptomes revealed 1307 differentially expressed genes (DEGs; 648 up, 659 down) and 1271 DEGs (645 up, 626 down) in fibroblasts derived from endometria without or with endometrosis, respectively. Enrichment analyses implicated cellular metabolism, extracellular matrix (ECM) organization and remodeling, and signaling pathways commonly linked to fibrogenesis. IL‑4 also affected the long non‑coding RNA (lncRNA) expression, with 143 and 135 differentially expressed lncRNAs in fibroblasts derived from healthy or fibrotic endometria, respectively; linking these lncRNAs to DEGs involved in inflammation, ECM organization, and cytokine signaling. Moreover, IL‑4 increased proliferation and viability in fibroblasts derived from healthy or fibrotic endometria, while selectively reducing migration in fibroblasts derived from endometria without fibrosis after 96 h. IL‑4 further altered mRNA expression, protein abundance, and gelatinolytic activity of matrix metalloproteinases in a manner contingent on the fibrosis status of the tissue of origin, indicating stage‑dependent control of ECM turnover. Collectively, these data identify IL‑4 as a potent modulator of fibroblast function in a spontaneous large‑animal fibrosis model, revealing fibrosis stage‑dependent responses. Graphical Abstract Interleukin-4 (IL-4) modulates the transcriptome, extracellular matrix (ECM)–associated components, and functional characteristics of mare endometrial fibroblasts derived from healthy and fibrotic uteri. IL-4 treatment induces distinct transcriptomic and proteomic changes, alters cell proliferation, migration, collagen contractility, and MMP activity, and elicits differential responses between non-fibrotic and fibrotic cells, highlighting fibrosis-dependent effects of IL-4 on endometrial remodeling. Similar content being viewed by others Data availability The raw reads have been deposited in the Sequence Read Archive (SRA) under accession number PRJNA1154451.

References

Allen JE (2023) IL-4 and IL-13: regulators and effectors of wound repair. Annu Rev Immunol 41:229–254 Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245–5250 Aoudjehane L, Pissaia AJ, Scatton O, Podevin P, Massault PP, Chouzenoux S, Soubrane O, Calmus Y, Conti F (2008) Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway. Lab Invest 88:973–985 Arpino V, Brock M, Gill SE (2015) The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol 44–46:247–254 Arthur MJ, Iredale JP, Mann DA (1999) Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 23:940–943 Barron L, Wynn TA (2011) Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages. Am J Physiol Gastrointest Liver Physiol 300:G723–G728 Batsaikhan B, Lu MY, Yeh ML, Huang CI, Huang CF, Lin ZY, Chen SC, Huang JF, Hsieh PH, Chuang WL, Lee JC, Yu ML, Dai CY (2019) Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C. J Chin Med Assoc 82:277–281 Bhattacharya M, Ramachandran P (2023) Immunology of human fibrosis. Nat Immunol 24:1423–1433 Bracher V, Mathias S, Allen WR (1996) Influence of chronic degenerative endometritis (endometrosis) on placental development in the mare. Equine Vet J 28:180–188 Bukowska J, Kopcewicz M, Kur-Piotrowska A, Szostek-Mioduchowska AZ, Walendzik K, Gawronska-Kozak B (2018) Effect of TGFbeta1, TGFbeta3 and keratinocyte conditioned media on functional characteristics of dermal fibroblasts derived from reparative (Balb/c) and regenerative (Foxn1 deficient; nude) mouse models. Cell Tissue Res 374:149–163 Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL (2009) BLAST+: architecture and applications. BMC Bioinformatics 10:421 Cui X, Shi E, Li J, Li Y, Qiao Z, Wang Z, Liu M, Tang W, Sun Y, Zhang Y, Xie Y, Zhen J, Wang X, Yi F (2022) GPR87 promotes renal tubulointerstitial fibrosis by accelerating glycolysis and mitochondrial injury. Free Radic Biol Med 189:58–70 D’Arcy Q, Gharaee-Kermani M, Zhilin-Roth A, Macoska JA (2022) The IL-4/IL-13 signaling axis promotes prostatic fibrosis. PLoS One 17:e0275064 Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15–21 Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B (1998) IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 10:1421–1433 Flores JM, Rodriguez A, Sanchez J, Gomezcuetara C, Ramiro F (1995) Endometriosis in mares - incidence of histopathological alterations. Reprod Domest Anim 30:61–65 Giannandrea M, Parks WC (2014) Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech 7:193–203 Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74:111–122 Gu Z (2022) Complex heatmap visualization. Imeta 1:e43 Han S, Liang Y, Ma Q, Xu Y, Zhang Y, Du W, Wang C, Li Y (2019) Lncfinder: an integrated platform for long non-coding RNA identification utilizing sequence intrinsic composition, structural information and physicochemical property. Brief Bioinform 20:2009–2027 Henderson J, O’Reilly S (2021) The emerging role of metabolism in fibrosis. Trends Endocrinol Metab 32:639–653 Henderson NC, Rieder F, Wynn TA (2020) Fibrosis: from mechanisms to medicines. Nature 587:555–566 Hofacker IL, Fontana W, Stadler PF, Bonhoeffer LS, Tacker M, Schuster P (1994) Fast folding and comparison of RNA secondary structures. Monatsh Chem 125:167–188 Hoffmann C, Ellenberger C, Mattos RC, Aupperle H, Dhein S, Stief B, Schoon HA (2009) The equine endometrosis: new insights into the pathogenesis. Anim Reprod Sci 111:261–278 Hong KH, Cho ML, Min SY, Shin YJ, Yoo SA, Choi JJ, Kim WU, Song SW, Cho CS (2007) Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblasts. Clin Exp Immunol 147:573–579 Huaux F, Liu T, McGarry B, Ullenbruch M, Phan SH (2003) Dual roles of IL-4 in lung injury and fibrosis. J Immunol 170:2083–2092 Hwang S, Chung KW (2021) Targeting fatty acid metabolism for fibrotic disorders. Arch Pharm Res 44:839–856 Kenney RM, Doig PA (1986) Equine endometrial biopsy. In: Morrow DA (ed) Current therapy in theriogenology, pp 723–29 Kotlowska M, Kowalski R, Glogowski J, Jankowski J, Ciereszko A (2005) Gelatinases and serine proteinase inhibitors of seminal plasma and the reproductive tract of turkey (Meleagris gallopavo). Theriogenology 63:1667–1681 Lehmann J, Ellenberger C, Hoffmann C, Bazer FW, Klug J, Allen WR, Sieme H, Schoon HA (2011) Morpho-functional studies regarding the fertility prognosis of mares suffering from equine endometrosis. Theriogenology 76:1326–1336 Liu X, Conner H, Kobayashi T, Abe S, Fang Q, Wen FQ, Rennard SI (2003) Synergetic effect of interleukin-4 and transforming growth factor-beta1 on type I collagen gel contraction and degradation by HFL-1 cells: implication in tissue remodeling. Chest 123:427S-S428 Lorenz R, Bernhart SH, Honer Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL (2011) ViennaRNA Package 2.0. Algorithms Mol Biol 6:26 Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550 Lupher ML Jr., Gallatin WM (2006) Regulation of fibrosis by the immune system. Adv Immunol 89:245–288 Miki H, Manresa MC (2023) Novel fibroblast phenotypes in homeostasis and chronic inflammation: from functions to potential regulators. J Physiol 601:2273–2291 Padmanabhan J, Maan ZN, Kwon SH, Kosaraju R, Bonham CA, Gurtner GC (2019) In vivo models for the study of fibrosis. Adv Wound Care 8:645–654 Peng H, Sarwar Z, Yang XP, Peterson EL, Xu J, Janic B, Rhaleb N, Carretero OA, Rhaleb NE (2015) Profibrotic role for interleukin-4 in cardiac remodeling and dysfunction. Hypertension 66:582–589 Pertea G, Pertea M (2020) GFF utilities: GffRead and GffCompare. F1000Res. https://doi.org/10.12688/f1000research.23297.2 Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL (2015) StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 33:290–295 Rabbani N, Thornalley PJ (2019) Hexokinase-2 glycolytic overload in diabetes and ischemia-reperfusion injury. Trends Endocrinol Metab 30:419–431 Rosenbloom J, Macarak E, Piera-Velazquez S, Jimenez SA (2017) Human fibrotic diseases: current challenges in fibrosis research. Methods Mol Biol 1627:1–23 Sempowski GD, Beckmann MP, Derdak S, Phipps RP (1994) Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 152:3606–3614 Smolgovsky S, Theall B, Wagner N, Alcaide P (2024) Fibroblasts and immune cells: at the crossroad of organ inflammation and fibrosis. Am J Physiol Heart Circ Physiol 326:H303–H316 Steinke JW, Crouse CD, Bradley D, Hise K, Lynch K, Kountakis SE, Borish L (2004) Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 30:212–219 Szóstek-Mioduchowska A, Wójtowicz A, Sadowska A, Moza Jalali B, Slyszewska M, Lukasik K, Gurgul A, Szmatola T, Bugno-Poniewierska M, Ferreira-Dias G, Skarzynski DJ (2023) Transcriptomic profiling of mare endometrium at different stages of endometrosis. Sci Rep 13:16263 Tian Y, Duan C, Feng J, Liao J, Yang Y, Sun W (2023) Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: a review. Int J Biochem Cell Biol 155:106361 Ung CY, Onoufriadis A, Parsons M, McGrath JA, Shaw TJ (2021) Metabolic perturbations in fibrosis disease. Int J Biochem Cell Biol 139:106073 Wang S, Liang Y, Dai C (2022) Metabolic regulation of fibroblast activation and proliferation during organ fibrosis. Kidney Dis (Basel) 8:115–125 Wen FQ, Kohyama T, Liu X, Zhu YK, Wang H, Kim HJ, Kobayashi T, Abe S, Spurzem JR, Rennard SI (2002) Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma. Am J Respir Cell Mol Biol 26:484–490 Wickham H (2016) Data analysis. In Hadley Wickham (ed.), ggplot2: Elegant Graphics for Data Analysis (Springer International Publishing: Cham) Willems M, Olsen C, Caljon B, Vloeberghs V, De Schepper J, Tournaye H, Van Saen D, Goossens E (2022) Transcriptomic differences between fibrotic and non-fibrotic testicular tissue reveal possible key players in Klinefelter syndrome-related testicular fibrosis. Sci Rep 12:21518 Witkowski M, Duliban M, Rak A, Profaska-Szymik M, Gurgul A, Arent ZJ, Galuszka A, Kotula-Balak M (2022) Next-generation sequencing analysis discloses genes implicated in equine endometrosis that may lead to tumorigenesis. Theriogenology 189:158–166 Wu YS, Liang S, Li DY, Wen JH, Tang JX, Liu HF (2021) Cell cycle dysregulation and renal fibrosis. Front Cell Dev Biol 9:714320 Wynn TA (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4:583–594 Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18:1028–1040 Yin X, Choudhury M, Kang JH, Schaefbauer KJ, Jung MY, Andrianifahanana M, Hernandez DM, Leof EB (2019) Hexokinase 2 couples glycolysis with the profi brotic actions of TGF-beta. Sci Signal 12:eaax4067 Yu G, Wang LG, Han Y, He QY (2012) Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS 16:284–287 Zhao M, Wang L, Wang M, Zhou S, Lu Y, Cui H, Racanelli AC, Zhang L, Ye T, Ding B, Zhang B, Yang J, Yao Y (2022) Targeting fibrosis, mechanisms and cilinical trials. Signal Transduct Target Ther 7:206 Zhao S, Fernald RD (2005) Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol 12:1047–64

Acknowledgements

The authors would like to thank Agnieszka Bacławska, Witold Krzywiec, Ewa Liszewska, and Krzysztof Witek from the Institute of Animal Reproduction and Food Research, PAS, Olsztyn, for their technical support. Graphical abstract was created using images from Servier Medical Art (https://smart.servier.com), licensed under a Creative Commons Attribution 3.0 Unported License (CC BY 3.0). Funding This study was carried out as a part of the Sonata project (2019/35/D/NZ9/02989), financed by the National Science Centre, Poland. Author information Authors and Affiliations Contributions A.W.—writing original draft, study design, methodology, formal analysis, visualization, investigation, statistical analysis; A.S—investigation; K.M.—bioinformatic analysis of NGS results, visualization; T.M.—bioinformatic analysis of NGS results, visualization; M.M.K.—formal analysis; A.S.-M.—conceptualization, study design, funding acquisition, methodology, formal analysis, editing original draft. Corresponding author Ethics declarations Ethics approval This study used mare endometrial tissue obtained post-mortem from mares at a commercial slaughterhouse, where the animals were processed solely for meat production. As the samples were collected after death from non-experimental animals, no ethical approval was required. Competing interests The authors declare no competing interests. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information Below is the link to the electronic supplementary material. ESM 1 (download DOCX ) (5.25 MB DOCX) ESM 2 (download XLSX ) (765 KB XLSX) Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Wójtowicz , A., Sadowska, A., Myszczyński, K. et al. Interleukin-4 changes the transcriptome, ECM-associated components and function of mare endometrial fibroblast: Insights from healthy and fibrotic cells. Cell Tissue Res 403, 25 (2026). https://doi.org/10.1007/s00441-026-04049-6 Received: Accepted: Published: Version of record: DOI: https://doi.org/10.1007/s00441-026-04049-6

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (57)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK